Expert Consensus on Clobazam in the Treatment of Refractory Epilepsy (2022)

Expert Consensus on Clobazam in the Treatment of Refractory Epilepsy (2022)

After regular anti-epileptic drug treatment, the symptoms of most patients with epilepsy can be well controlled or relieved, but 30%-40% of patients with epilepsy, after long-term drug treatment, still suffer from repeated seizures and develop refractory epilepsy. Lennox-Gastaut syndrome, Dravet syn...

Full description

Bibliographic Details
Main Author: Multi-disciplinary Team for Rare Diseases, Peking Union Medical College Hospital National Rare Diseases Committee
Format: Article
Language:zho
Published: Editorial Office of Medical Journal of Peking Union Medical College Hospital 2022-09-01
Series:Xiehe Yixue Zazhi
Subjects:
clobazam
refractory epilepsy
expert consensus
rare diseases
orphan drug
Online Access:https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2022-0421

Internet

https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2022-0421

Similar Items